Copyright
©The Author(s) 2022.
World J Gastroenterol. Nov 7, 2022; 28(41): 5944-5956
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5944
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5944
Characteristics | No TIPS | TIPS | P value |
Patients | 398 | 214 | |
Male | 269 (68%) | 153 (71%) | 0.320 |
Age (yr) | 59.5 (26.4-93.4) | 59.1 (29.9-80.7) | 0.190 |
Cause of cirrhosis | 0.130 | ||
-Alcohol | 305 (77%) | 179 (84%) | |
-Viral hepatitis | 11 (3%) | 4 (2%) | |
-Other | 82 (21%) | 31 (14%) | |
Child points (min-max) | 10 (7-15) | 9 (7-14) | < 0.001 |
Hepatic encephalopathy (West-Haven) | 0.040 | ||
-None | 276 (69%) | 165 (77%) | |
-Grade 1-2 | 73 (18%) | 30 (14%) | |
-Grade 3-4 | 49 (12%) | 19 (9%) | |
ACLF grade at hospital admission | 0.020 | ||
-No ACLF | 294 (74%) | 173 (81%) | |
-ACLF grade 1 | 64 (16%) | 39 (18%) | |
-ACLF grade 2 | 32 (8%) | 1 (0.5%) | |
-ACLF grade 3 | 8 (2%) | 1 (0.5%) | |
Laboratory findings | |||
-Meld | 18 (7-40) | 14 (7-40) | < 0.001 |
-Total bilirubin (μmol/L) | 49.7 (5.9-668.0) | 28.1 (6.1-688.5) | < 0.001 |
-Creatinine (μmol/L) | 100.5 (23.1-781.0) | 107.0 (42.3-783.5) | 0.180 |
-INR | 1.45 (0.92-9.2) | 1.28 (0.97-2.5) | < 0.001 |
-Sodium (μmol/L) | 134 (106-149) | 133 (115-146) | 0.760 |
-Albumin (g/L) | 22.6 (7.9-48.7); NA: 55 | 26.1 (11.0-39.6); NA: 23 | < 0.001 |
-CRP (mg/L) | 25.6 (1.0-283.0) | 18.0 (2.0-181.0) | < 0.001 |
-Hemoglobin (mmol/L) | 6.8 (2.0-9.8) | 6.7 (3.4-10.0) | 0.310 |
-Platelets (Gpt/L) | 134.5 (22.0-715.0) | 153.5 (13.0-668.0) | 0.002 |
-Leucocytes (Gpt/L) | 8.76 (1.34-44.90) | 7.34 (2.72-33.20) | < 0.001 |
- Citation: Philipp M, Blattmann T, Bienert J, Fischer K, Hausberg L, Kröger JC, Heller T, Weber MA, Lamprecht G. Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison. World J Gastroenterol 2022; 28(41): 5944-5956
- URL: https://www.wjgnet.com/1007-9327/full/v28/i41/5944.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i41.5944